Table 2.

Indirect MAIPA with serum and IgG fractions, in the absence and presence of gold

CaseSerumPurified IgG
Native sampleGold (μg/mL)*Native sampleGold (μg/mL)
0.11100.1110
Control 0.01 0.00 0.00 0.00 0.15 0.12 0.13 0.12 
0.43 0.34 0.36 0.30 0.49 0.41 0.23 0.39 
1.39 1.14 1.93 1.04 0.46 0.31 0.35 0.23 
0.38 0.28 0.39 0.23 0.34 0.19 0.27 0.17 
0.33 0.24 0.24 0.18 0.56 0.48 0.48 0.53 
1.12 0.95 1.02 0.97 1.74 1.40 1.45 1.32 
CaseSerumPurified IgG
Native sampleGold (μg/mL)*Native sampleGold (μg/mL)
0.11100.1110
Control 0.01 0.00 0.00 0.00 0.15 0.12 0.13 0.12 
0.43 0.34 0.36 0.30 0.49 0.41 0.23 0.39 
1.39 1.14 1.93 1.04 0.46 0.31 0.35 0.23 
0.38 0.28 0.39 0.23 0.34 0.19 0.27 0.17 
0.33 0.24 0.24 0.18 0.56 0.48 0.48 0.53 
1.12 0.95 1.02 0.97 1.74 1.40 1.45 1.32 

Native samples are samples without gold added.

*

Final concentration of gold during all stages of MAIPA. For clarity, results using 100 μg/mL are not shown.

Negative control AB serum or IgG fraction from AB serum.

ELISA OD values. Results are from a representative experiment, derived from duplicate testing against platelets from 2 donors.

or Create an Account

Close Modal
Close Modal